Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2022-12-09 Director's Dealing
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their shareholdings, which falls under the 'Director's Dealing' category (DIRS) in the provided classification schema.
2022-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes in ownership. This falls under the 'Director's Dealing' category as it reports the share ownership status of an executive (Lee Hyun Kul) following a corporate merger.
2022-12-09 Korean
증권발행실적보고서(합병등)
Share Issue/Capital Change Classification · 1% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of a merger between Corestem Co., Ltd. and Chemon Co., Ltd., including the issuance of new shares, share purchase rights, and creditor protection procedures. This is a formal regulatory filing documenting the final results of a corporate action (merger). Since it does not fit into specific categories like 10-K or Earnings Release, and is a formal regulatory report rather than a simple announcement, it falls under the 'Regulatory Filings' category.
2022-12-02 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding the change of the company's Representative Director (CEO). It details the outgoing director, the incoming director (Yang Gil-an), the reason for the change, and the date of the board resolution. This falls directly under the category of Board/Management Information (MANG).
2022-12-02 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Corestem Inc., covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, management discussions, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-11 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results from an Extraordinary General Meeting (EGM) of shareholders for the company 'Corestem'. It details the voting results for specific agenda items (merger agreement approval, director compensation limits), lists newly appointed directors, and outlines changes to business objectives. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it provides the official outcome of shareholder resolutions.
2022-10-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.